It represents a possible situational intervention with fast onset that doesn't carry the dependence profile of benzodiazepines. Regulatory standing as of 2025–2026 warrants verification with present FDA databases.Has a large prospective for abuse. Has no at present acknowledged healthcare use in treatment in the United States. There's a lack of r